These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7063020)

  • 1. Effects of Duchenne muscular dystrophy on muscle protein synthesis.
    Rennie MJ; Edwards RH; Millward DJ; Wolman SL; Halliday D; Matthews DE
    Nature; 1982 Mar; 296(5853):165-7. PubMed ID: 7063020
    [No Abstract]   [Full Text] [Related]  

  • 2. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
    Ballard FJ; Tomas FM; Stern LM
    Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo estimation of muscle protein synthesis in myotonic dystrophy.
    Halliday D; Ford GC; Edwards RH; Rennie MJ; Griggs RC
    Ann Neurol; 1985 Jan; 17(1):65-9. PubMed ID: 3985589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Content of methylhistidines in normal and pathological human skeletal muscles.
    Mussini E; Cornelio F; Dworzak F; Cotellessa L; Morandi L; Colombo L; De Ponte G; Marcucci F
    Muscle Nerve; 1983; 6(6):423-9. PubMed ID: 6621612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incorporation of 3H (G) L-leucine into single muscle fibers in Duchenne dystrophy and Charcot-Marie Tooth disease.
    Monckton G; Marusyk H
    Can J Neurol Sci; 1979 Feb; 6(1):53-7. PubMed ID: 264156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-methylhistidine excretion in myotonic dystrophy.
    Griggs RC; Moxley RT; Forbes GB
    Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulatory effects of drugs for protein synthesis on muscle cell cultures in Duchenne dystrophy.
    Ionasescu V; Stern LZ; Ionasescu R; Rubenstein P
    Ann Neurol; 1979 Feb; 5(2):107-10. PubMed ID: 426472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of muscle wasting in myotonic dystrophy.
    Griggs RC; Jozefowicz R; Kingston W; Nair KS; Herr BE; Halliday D
    Ann Neurol; 1990 May; 27(5):505-12. PubMed ID: 2360792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    McKeran RO; Halliday D; Purkiss P
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy.
    Stewart PM; Walser M; Drachman DB
    Muscle Nerve; 1982 Mar; 5(3):197-201. PubMed ID: 7088016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle wasting in muscular dystrophy: decreased protein synthesis or increased degradation?
    Griggs RC; Rennie MJ
    Ann Neurol; 1983 Feb; 13(2):125-32. PubMed ID: 6338807
    [No Abstract]   [Full Text] [Related]  

  • 13. Abnormal protein synthesis in facioscapulohumeral muscular dystrophy.
    Ionasescu V; Zellweger H; Shirk P; Conway TW
    Neurology; 1972 Dec; 22(12):1286-92. PubMed ID: 4675677
    [No Abstract]   [Full Text] [Related]  

  • 14. Myofibrillar incorporation of 3H (G) L-leucine in pgrogressive muscular dystrophy and motor neuron disease.
    Monckton G; Marusyk H
    Neurology; 1976 Mar; 26(3):234-7. PubMed ID: 943052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosomal protein synthesis in Duchenne muscular dystrophy.
    Ionasescu V; Zellweger H; Conway TW
    Arch Biochem Biophys; 1971 May; 144(1):51-8. PubMed ID: 5117538
    [No Abstract]   [Full Text] [Related]  

  • 16. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
    Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural proteins of the opaque muscle fibers in Duchenne muscular dystrophy.
    Uchino M; Araki S; Yoshida O; Uekawa K
    Neurology; 1985 Sep; 35(9):1364-7. PubMed ID: 4022387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of carriers of Duchenne muscular dystrophy by muscle protein synthesis.
    Ionasescu V; Zellweger H; Shirk P; Conway TW
    Neurology; 1973 May; 23(5):497-502. PubMed ID: 4735465
    [No Abstract]   [Full Text] [Related]  

  • 19. Protein synthesis in muscle cultures from patients with Duchenne muscular dystrophy. Calcium and A23187 ionophore dependent changes.
    Ionasescu V; Zellweger H; Ionasescu R; Lara-Braud C; Cancilla PA
    Acta Neurol Scand; 1976 Sep; 54(3):241-7. PubMed ID: 785934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of protein synthesis in skeletal muscle of normal man and patients with muscular dystrophy: a reassessment.
    Halliday D; Pacy PJ; Cheng KN; Dworzak F; Gibson JN; Rennie MJ
    Clin Sci (Lond); 1988 Mar; 74(3):237-40. PubMed ID: 3345633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.